Day: March 23, 2020

VICTOR, N.Y., March 23, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, today commented on the impact of recent northern and southern border closures in the U.S. and impact of the COVID-19 virus on U.S. market trends.“Our hearts go out to those impacted by this terrible virus,” said Bill Newlands, president and chief executive officer at Constellation Brands. “Now, more than ever, it is imperative that the public and private sectors in the U.S. and both countries work together to keep residents safe and healthy, while continuing to support our global economy, supply chain, and the many jobs our respective citizens depend on to make ends meet.”Newlands continued, “Importantly, recent decisions to close the northern and southern borders of the U.S. do not impact commercial...

         Pennsauken, N.J., March 23, 2020 (GLOBE NEWSWIRE) —  J & J Snack Foods Corp. (NASDAQ-JJSF)  announced today that the virtual shutdown of large segments of the US economy resulting from the efforts to limit the spread of the coronavirus (COVID-19)  is having a material impact on its sales and operations and that it expects its results of operations to be materially negatively impacted. The Company said that it is unable to estimate what the impact will be although it said the impact will be material.  In a press release dated March 12, 2020, the Company had indicated that approximately 1/3 of its annual revenue was to venues and locations that it said it believed would be primarily impacted. With the expansion of government shutdown orders, the Company now says that 2/3 of its annual revenue of approximately $1.2 billion...

CALGARY, Alberta, March 23, 2020 (GLOBE NEWSWIRE) — Athabasca Minerals Inc. (“AMI” or the “Corporation”) – TSXV:AMI – is pleased to announce:The opening of Coffey Lake Public Pit (“Coffey Lake”) and its first deliveries of aggregates for customers in the Ft. McMurray industrial region.Provincial approval of a 30 hectare (72 acre) commercial lease, which serves as AMI’s True North Staging Hub (“True North Hub”) for crushing and stockpiling aggregates near oilsands industrial operations and associated infrastructure projects.Expansion of its business interests into Ontario with a 50/50 joint venture, together with MGT Management Inc., to develop a limestone quarry (“Buckhorn Quarry”) on 300 acres of land approximately 90 kilometers from the Greater Toronto Area (GTA).  The prospective Buckhorn Quarry is planned to supply products...

TORONTO, March 23, 2020 (GLOBE NEWSWIRE) — Sprott Resource Holdings Inc. (“SRHI” or the “Company”) (TSX: SRHI) today provided an update relating to the COVID-19 related market uncertainty and an update on the immediate impact to the Company’s copper mining operations at Minera Tres Valles (“MTV”) located in Salamanca, Chile.“The constantly changing and escalating COVID-19 situation is unprecedented and for many is a time filled with uncertainty and concern,” said Michael Harrison, Interim President and CEO. “The safety of our employees is of the utmost importance to us. We previously implemented work-from-home mandates for our corporate and office employees and increased both employee education and sanitization at the mine site. All individuals entering the mine site are monitored for symptoms including elevated temperatures.”On...

BETHESDA, Md., March 23, 2020 (GLOBE NEWSWIRE) — AllSurplus, the leading global marketplace for selling and buying surplus assets, is pleased to announce it has launched a free program for small businesses to list and sell surplus equipment to raise capital to meet their needs. This program enables small businesses to respond to the changing business climate and quickly generate liquidity by selling surplus and idle assets through a safe, trusted and secure B2B online auction marketplace. AllSurplus.com sells assets in over 100 categories and currently features nearly 5,000 assets for sale. The marketplace is powered by Liquidity Services (NASDAQ: LQDT) and leverages its 20 years of experience selling over $8.0 billion in business assets.“Small businesses are the backbone of our global economy. Given the current environment, it...

NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that CAPLYTA (lumateperone) is now available to pharmacies in the U.S. CAPLYTA is an oral, once daily medicine approved for the treatment of schizophrenia in adults.“At Intra-Cellular Therapies, we understand the lifelong debilitating struggle people with schizophrenia experience.  The need for new treatment options for this community has driven our efforts to bring CAPLYTA to market,” said Mark Neumann, Chief Commercial Officer of Intra-Cellular Therapies.  “We have an experienced commercial team and have developed a comprehensive strategy with a multi-channel promotional plan to support...

EDMONTON, Alberta, March 23, 2020 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate” or “the Company”) is pleased to announce it has shipped its first Internet of Things (IoT) buttons to hospitals in Vancouver, BC, marking the initial deployment of the new technology developed by the Company.The buttons, called Wanda QuickTouch, were developed to address the need for rapid deployment in a facility of any size. The IoT buttons send instant alerts to management advising of any cleaning or maintenance issues that may pose risks to the public safety. The technology enables facility managers to track alerts and staff response times, as well as monitor regular cleaning activities in the high-traffic areas.“COVID-19 has demonstrated the need for facilities to be proactive on cleaning issues,” explains John Putters, CEO of...

S. Louise Phanstiel Appointed Chair of the Board of Directors; John T. Henderson, M.D., to Remain on the BoardSALT LAKE CITY, March 23, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced today that S. Louise Phanstiel has been appointed as chair of the Board of Directors.  John T. Henderson, M.D., will remain on the Board of Directors.“I would like to thank John for his numerous contributions to Myriad as chair of the board.  Under his tenure, Myriad has undergone dramatic diversification and growth,” said S. Louise Phanstiel, chair of the Board of Directors at Myriad Genetics. “I look forward to working with the board and management team at Myriad Genetics to ensure we maintain our global leadership in precision medicine.”“This change in the leadership...

– Phase 1 Healthy Volunteers Study Expected to Begin in Mid-Year 2020 –CAMBRIDGE, Mass., March 23, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for AG-946, a next-generation pyruvate kinase-R (PKR) activator. FDA has completed its 30-day safety review and granted approval to proceed with the proposed Phase 1 healthy volunteers study.“As our eighth IND in just 10 years, AG-946 demonstrates the consistent productivity of our research engine and our leadership in the understanding of PKR activation,” said Bruce Car, Ph.D., chief scientific officer at Agios. “By advancing AG-946 into the clinic, we have the opportunity to expand our PKR activation program and build on the expertise...

REDWOOD CITY, Calif., March 23, 2020 (GLOBE NEWSWIRE) — Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) for the research and development of novel gene therapies for certain disease indications, including the treatment of lysosomal storage disorders and blood factor deficiencies.Under the terms of the agreement, Codexis will generate novel gene sequences encoding protein variants tailored to enhance efficacy as a result of increased activity, stability, and cellular uptake using its CodeEvolver® protein engineering platform. Takeda will combine these improved transgenes with its gene therapy capabilities to generate novel candidates for the treatment of rare genetic...